Ketamine use for the dual purpose of sedation and analgesia in the critical care setting has been increasing dramatically. Ketamine has a unique pharmacologic mechanism of action that has been shown to be effective for various types of pain, sedation and other indications such as alcohol withdrawal, which are commonly seen in an intensive care setting. This podcast with review basic pharmacology and dosing of ketamine and provide guidance on appropriate patient selection for ketamine use in the ICU.
SPEAKERS
Maria Foy, PharmD, BCPS, CPE is a clinical pharmacy specialist in Palliative Care at Jefferson Abington Hospital Jefferson Health. Maria graduated from Temple University with a BS in Pharmacy and received a non-traditional PharmD from the University of the Sciences in Philadelphia. In 2013, Maria earned her board certification in pharmacotherapy (BCPS). Maria has lectured on pain management, symptom management, chronic pain and substance use disorder topics nationally and locally.
Danielle Schulingkamp, RPh, BCPS, BCCCP is a clinical pharmacy specialist in Critical Care/Surgical-Trauma at Jefferson Abington Health in Abington, PA. Her professional interests include traumatic brain injury/neuro critical care, substance withdrawal management, and sedation optimization. Additionally, she serves as the PGY2 Critical Care Pharmacy Residency Program Director.
Bhavik Shah, PharmD earned his doctorate of pharmacy from Rutgers University, and completed post-graduate training in pharmacy practice and infectious diseases at Thomas Jefferson University Hospital in Philadelphia, PA. He is an associate professor at the Jefferson College of Pharmacy and co-director of the Pharmacology thread in the JeffMD curriculum at SIdney Kimmel Medical College at Thomas Jefferson University. He is an active member of ASHP and ACCP. Within ASHP, he has served as vice-chair and is currently the chair of the Year-Round Educational Steering Committee for 2020-2021.